CG Oncology Inc - CGON Future Profit

CGON (CG Oncology Inc) - company brandmark

Earnings expectations for CG Oncology, Inc. (CGON) demonstrate the potential of a biopharmaceutical business currently investing in trials to secure an FDA monopoly. The upward price action is supported by acquisition prospects from industry behemoths and the success of the drug cretostimogene. This revolutionary therapy replaces surgical organ removal, facilitating a commercial launch. The value of expresses the metric level, capturing the issuer's current yield forecast.

CGON: cgoncology.com Future Profit 07/04/2022 - 11/18/2026

CG Oncology Corp - analytical breakdowns and key metrics (CGON)

- price and consensus price forecast:
Fundamental company analysis:CG Oncology Inc, CGON
Core merchandise of CG Oncology Inc

For comparative asset analysis, the investor utilizes this indicator as an aggregator of expected net income calculated based on consensus forecasts of future cash flows. In the case of CG Oncology, Inc. (CGON), the projected profit trend depends directly on R&D efficiency and the stability of production outsourcing via CMOs, making this chart a key marker of the business's operational resilience.

Analysis of competing companies

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings URGN (urogen.com)|BCAX - Future Profit|PSNL: Future Profit|ERAS - Projected Future Earnings|Delcath (DCTH) - Expected Profit|YmAbs - Expected Net Income|AURA (Aura Biosciences Inc) - Projected Future Earnings|Expected Net Profit Candel Therapeutics CADL|Projected Future Earnings ARAY|SLS - Expected Net Profit|Projected Future Earnings ACTU (Actuate Therapeutics Inc)|Company Profit Forecast Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Projected Future Earnings|Expected Net Profit Protara Therapeutics, Inc.|FATE: Projected Future Earnings|WHWK - Company Profit Forecast|Expected Profit TScan Therapeutics, Inc.|Champions Oncology - Forward Earnings|Projected Future Earnings XBIT|Company Profit Forecast CEL-SCI Corp|Expected Profit OS Therapies OSTX|Expected Net Income RADX|artivabio.com - Projected Future Earnings|Expected Net Income ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Future Profit|TPST: Future Net Profit|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit